0.00
—
Close of 30 Oct 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About HH Biotechnology Holdings
Its shares trade under the ticker HHBT. It has been listed since 23 July 2012. In the fiscal year to 31 December 2015, it reported revenue of $8.0m and net income of $2.5m. At that date it held total assets of $46.5m and shareholders' equity of $28.2m.
HH Biotechnology Holdings Co. through its various subsidiaries, is engaged in the commercial and residential real estate leasing, management, consulting, investment, development and sales in the city of Shenyang, Liaoning Province, in the People' Republic of China. The company is headquartered in Shenyang, Liaoning. The company went IPO on 2012-07-23. The firm's business segments are Property for sale, and Rental income and Income of management fee of commercial buildings. The firm conducts all operations through its direct and indirect subsidiaries, which include Shenyang Maryland International Industry Company Limited and Silverstrand International Holdings Company Limited. The company is focused primarily on real estate leasing, management and consulting activities in the city of Shenyang. The firm's leasing and management services are conducted primarily with respect to its real estate projects, which include President Building, Chenglong Garden and the Maryland Building. The company also holds over 2,190 square meters of retail space in Qiyun New Village.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Real Estate
- Industry
- Real Estate Management & Development
- Listed since
- 23 Jul 2012
- Website
- greatchinaholdings.com ↗
Leadership
Pay as last reported
- Mr. Frank JiangChairman of the Board, since 2005$122,166
- Mr. Sheng JiangChief Executive Officer, Director, since 2016
- Ms. Lirong WangChief Financial Officer, since 2005$12,386
- Liang ZouVice President - Operations
- Sasaki KojiVice President of Marketing
- Kunpeng YuVice President - Production
- Shuang LiActing Secretary of the Board
- Ms. Huang YingDirector
- Mr. Yizhao ZhangIndependent Director
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- HH Biotechnology Holdings Co. focuses on Shenyang real estate leasing and management services.
- The company manages President Building, Chenglong Garden, and Maryland Building properties.
- HH Biotechnology Holdings Co. holds over 2,190 square meters of retail space in Qiyun New Village.
Weaknesses
- The company's operations are limited to Shenyang, Liaoning Province, China.
- HH Biotechnology Holdings Co. relies on subsidiaries for all business activities.
- The firm's business segments are Property for sale and Rental income only.
Opportunities
- HH Biotechnology Holdings Co. could expand into other Chinese cities for real estate development.
- The company may increase its retail space in Qiyun New Village for higher income.
- Shenyang Maryland International Industry Company Limited offers potential growth opportunities.
Threats
- Shenyang's real estate market may face downturns affecting leasing and sales.
- The company's reliance on a single city could lead to market volatility risks.
- HH Biotechnology Holdings Co. faces competition from other real estate firms in Shenyang.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.